Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
about
Urinary stone disease and obesity: Different pathologies sharing common biochemical mechanismsNew insights into the pathogenesis of renal calculiRole of insulin resistance in uric acid nephrolithiasisMetabolic syndrome and associated urolithiasis in adults enrolled in a community-based health program.Hypocitraturia in common bottlenose dolphins (Tursiops truncatus): assessing a potential risk factor for urate nephrolithiasisThe clinical research office of the endourological society percutaneous nephrolithotomy global study: Outcomes in the morbidly obese patient - a case control analysis.Safety and efficacy of ureteroscopic lithotripsy for stone disease in obese patients: a systematic review of the literature.Prevalence of kidney stones in the United States.Thiazide diuretic prophylaxis for kidney stones and the risk of diabetes mellitus.Metabolic syndrome and the genesis of uric acid stones.Recent advances in the pathophysiology of nephrolithiasis.The role of salt abuse on risk for hypercalciuriaEffectiveness of retrograde intrarenal stone surgery in obese patients.The association of increasing body mass index and kidney stone disease[Effect of the body mass index on outcomes of ureterorenoscopy for renal stones].Epidemiology and clinical pathophysiology of uric acid kidney stones.Systemic implications of urinary stone disease.Metabolic syndrome and nephrolithiasis.The association of nephrolithiasis with hypertension and obesity: a review.Prevalence of hyperoxaluria after bariatric surgery.Influence of lean and fat mass on bone mineral density and on urinary stone risk factors in healthy women.Dietary management of idiopathic hyperoxaluria and the influence of patient characteristics and compliance.Body fat content and distribution and urinary risk factors for nephrolithiasis.Body fat composition and occurrence of kidney stones in hypercalciuric children.The impact of obesity on benign and malignant urologic conditions.Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence.Stone formation and management after bariatric surgery.Epidemiology of stone disease across the world.Update on the evaluation of repeated stone formers.The kidney stone and increased water intake trial in steel workers: results from a pilot study.[Diagnosis and treatment of nephrolithiasis. What is established?].Association between body mass index, lipid profiles, and types of urinary stones.Metabolic syndrome and urologic diseases.Results of urinary dissolution therapy for radiolucent calculi.Effects of statin treatment with atorvastatin on urolithiasis-associated urinary metabolic risk factors: an experimental study.Updated epidemiologic study of urolithiasis in Turkey. I: Changing characteristics of urolithiasis.The impact of metabolic syndrome on long-term outcomes of percutaneous nephrolithotomy (PCNL).The influence of metabolic syndrome and its components on the development of nephrolithiasisThe effect of metabolic syndrome upon the success of varicocelectomy
P2860
Q26829240-F25182D1-0528-43FC-904B-826DE2716E18Q27026371-B0C63589-E8BC-4D55-8D0E-68C7D441AB08Q27694312-D3A92FFB-9AB1-417B-A471-CE66F3294235Q30424026-7FF34164-7FB8-4A4C-A6AE-F9CD2FCDC5A9Q33791178-7F4B4960-58D0-485B-BF2E-0983E2AED37BQ33843672-19642A56-5F65-4B81-83B7-0934FBD91E69Q34218369-8B47B735-6971-48F2-BD45-569F570202B4Q34267948-F4E53167-FA9F-42C4-8D4E-0CCCD2F31C63Q34615244-EF1805D0-5E39-4CC0-ACD3-AA92D8F17B4EQ34645361-6ACCDE96-455B-4047-9B8D-E2538735FD75Q34936316-2AC5762F-00BB-4559-9CCA-3F3F13C7912BQ34999809-F22A5FAA-2745-40C1-B030-CB9710119727Q35839030-A293F266-8A38-4D71-9C5A-45000359216CQ36033390-B32C6E53-85C4-43E7-9218-D7180A9338ECQ36043711-ED940D98-07B4-42F7-AD0E-25D38DB5431AQ36417612-C6C816F7-410C-455B-8871-A3118B778A4DQ36450723-2877553C-AB1B-4CFC-AED9-F6C0B4299F0BQ36451152-F3812E31-3A59-49F5-A893-ADBD080E365DQ37064844-33F38D94-7166-4BEA-BE2A-AEE9CB24D63BQ37088328-40670601-74B9-41C1-A667-0FF47290C64CQ37368017-C861EFA3-AD8D-41C3-99F3-D0C47C29A660Q37396300-CEBD6DBE-7F9D-41C3-812D-3DB8898CBB1AQ37426986-751E904F-3EB9-4D77-9A33-209956C6B781Q37887579-BE5ECBE9-3DF0-43FB-AF78-F7724946B24AQ38128169-1711AA97-3258-405C-B3D4-283D3B5F531BQ38201688-E3176758-BD5F-4CB2-AFB2-B122D317CD6DQ38409982-B52E292C-C61E-4F23-B4A7-5CB9BCE6AAB3Q39141674-F549D862-66CE-4066-BBDE-D29D6E4CA727Q39405280-B6C07B3A-017A-447F-A2FE-226497D623ABQ39733750-E3B0B404-BEA4-473F-9AC2-158BDB14CC23Q40132732-11CCA283-67F3-424A-B64F-A6FDC7BD5693Q42663198-6560D659-5268-4769-BD3F-7A398A186597Q42757693-67E2FD9E-A8DA-4D5E-BD11-E64552E121CFQ45135684-B7F8EAC4-77C7-4B17-89BB-0F3496D24E36Q47772087-DDC38A19-D328-45C9-B81A-891C71864090Q51156123-441FF1A4-8EED-43AA-9847-AB2B31E0CBD8Q54456099-840294D0-BB80-4065-B543-E575C0055445Q58588786-9B4BA71B-207A-4F30-BAD2-30979058868BQ58915170-972FE7B3-C3DA-4377-89D0-56CA11FC046D
P2860
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Metabolic risk factors and the ...... rolithiasis in obese patients.
@ast
Metabolic risk factors and the ...... rolithiasis in obese patients.
@en
type
label
Metabolic risk factors and the ...... rolithiasis in obese patients.
@ast
Metabolic risk factors and the ...... rolithiasis in obese patients.
@en
prefLabel
Metabolic risk factors and the ...... rolithiasis in obese patients.
@ast
Metabolic risk factors and the ...... rolithiasis in obese patients.
@en
P2093
P1476
Metabolic risk factors and the ...... rolithiasis in obese patients.
@en
P2093
Barbara J Mathias
David M Albala
Glenn M Preminger
Matthew D Young
Michaella E Maloney
Philipp Dahm
Wesley O Ekeruo
Yeh Hong Tan
P304
P356
10.1097/01.JU.0000128574.50588.97
P407
P577
2004-07-01T00:00:00Z